eDevice Receives Tadi Award for the Design of Its New HealthGO Mini Platform

eDeviceHealthGO Mini is a healthcare device directly installed at patients' homes, transmitting vital signs (i.e. blood pressure, weight, oxygen saturation) to medical information systems through the secure eDevice mobile network. HealthGO Mini communicates with medical sensors via Bluetooth or USB. It can be combined with a tablet, offering a powerful user interface for medical applications such as Q&A for disease management.

eDevice has been awarded the renowned Tadi Award for the design of its HealthGO Mini. It also rewards the company's successful strategy that combines technological innovation and investments in product design. This approach allowed eDevice to differentiate itself in the booming market of eHealth and to become the leading provider of Remote Patient Monitoring solutions for healthcare device manufacturers.

Stéphane Schinazi, CEO of eDevice, declares: "The specific needs of chronically-ill patients, the home-and-office environment of our products and the market's regulatory requirements are three key factors that pushed eDevice to place the product design at the core of its strategy. For five years now, we’ve been working closely with the recognized and award-winning French designer Didier Garrigos. Together, we created ergonomic, easy-to-use medical products for patients and elderly people, while keeping a compact and unobtrusive form factor that perfectly blends into the lifestyle of the end-user."

Several innovating products emerged from this collaboration, from the WireX network converter, to the medical platform family HealthGO. More than 200,000 active products are deployed in 150 different countries across the globe, including in the United States where eDevice generates most of its revenue, this year reaching a steady triple digits growth rate.

These incredible results will reflect in new job opportunities within several departments at eDevice, including several new Engineer positions to be filled in 2016.

About eDevice
At the crossroads of telecom and medical fields, eDevice pioneered the Telehealth connectivity space. Since 2002, several market leaders have relied on eDevice to provide solutions that securely and safely transmit medical data between their patients and their systems, with continuous growth and more than 200,000 patients connected with eDevice technology. Based in Bordeaux, France, eDevice's team of experts enables the company to continue steady and profitable growth. Dedicated to quality, eDevice is ISO-9001 and ISO-13485 certified for design, production, marketing of modems and communicating equipment, and provision of global network telecommunication and data transmission services. eDevice develops solutions for M2M and eHealth connectivity, including Telehealth hubs, network converters, cellular modems, and 3G modules. The company also provides secure cellular network access, cellular data management services, as well as medical data storage and front-end application services for Remote Patient Monitoring. Through partnership with technology leaders, the company brings innovative connectivity solutions to medical device manufacturers.

Most Popular Now

European Artificial Intelligence Act Com…

The European Artificial Intelligence Act (AI Act), the world's first comprehensive regulation on artificial intelligence, enters into force. The AI Act is designed to ensure that AI developed and used...

Patient Safety must be Central to the De…

An EPR system brings together different patient information in one place, making it easier to access for healthcare professionals. This information can include patients' own notes, test results, observations by...

ChatGPT Shows Promise in Answering Patie…

The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®...

Survey: Most Americans Comfortable with …

Artificial intelligence (AI) is all around us - from smart home devices to entertainment and social media algorithms. But is AI okay in healthcare? A new national survey commissioned by...

AI Spots Cancer and Viral Infections at …

Researchers at the Centre for Genomic Regulation (CRG), the University of the Basque Country (UPV/EHU), Donostia International Physics Center (DIPC) and the Fundación Biofisica Bizkaia (FBB, located in Biofisika Institute)...

Video Gaming Improves Mental Well-Being

A pioneering study titled "Causal effect of video gaming on mental well-being in Japan 2020-2022," published in Nature Human Behaviour, has conducted the most comprehensive investigation to date on the...

New Diabetes Research Links Blood Glucos…

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs published a new study in Scientific Reports - confirming...

Machine learning helps identify rheumato…

A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to...

New AI Software could Make Diagnosing De…

Although Alzheimer's is the most common cause of dementia - a catchall term for cognitive deficits that impact daily living, like the loss of memory or language - it's not...

A New AI Tool for Cancer

Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers. The new AI system, described Sept...

Vision-Based ChatGPT Shows Deficits Inte…

Researchers evaluating the performance of ChatGPT-4 Vision found that the model performed well on text-based radiology exam questions but struggled to answer image-related questions accurately. The study's results were published...

Bayer Launches New Healthy-Aging Ecosyst…

Combining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging healthy-aging...